drugset / Trial / NCT01057849

Standard Comprehensive Intervention to Treat First-episode Schizophrenia

NCT01057849

RandomizedParallel-groupOpen-labelTreatment

Summary

Schizophrenia is not a curable but a treatable disease by antipsychotics. Kinds of atypical antipsychotics are widely used since 1990s' in China. Although their efficacy for acute phase are all better than typicals, individulized regimen of them for first-episode schizophrenia and their effectiveness in real naturalistic clinical settings still remain unclear. And those patients also need more comprehensive intervention such as psychosocial programs to improve their function. This protocol is to conduct a study in several sites of China to investigate the effectiveness of comprehensive intervention combining sequenced atypical antipsychotic therapy and intensive psychosocial intervention for first-episode schizophrenic patients. In addition, this protocol also aims at collecting such information as molecular genetics, neurochemical test, neucognitive performance and neuroimaging for outcome analysis.

Timeline

Start
2008-09
Primary completion
2011-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 10 mg
Subject Aripiprazole Other / unclassified 30 mg
Subject Olanzapine Small molecule 5 mg
Subject Olanzapine Small molecule 20 mg
Subject Risperidone Other / unclassified 3 mg
Subject Risperidone Other / unclassified 6 mg

Indications